Increased abundance of labile intracellular zinc during cell proliferation was due to increased retention of extracellular zinc in 3T3 cells.
Platelet-derived growth factor (PDGF)-, epidermal growth factor (EGF)- and insulin-like growth factor I (IGF-I)-stimulated cell proliferation in 3T3 cells was accompanied by increased abundance of labile intracellular pool of zinc (LIPZ). However, the origin and regulation of this cell proliferation-associated increase in the abundance of LIPZ are unknown. Cellular zinc homeostasis involves zinc transporters and metallothionein. The objectives of this study were to determine whether cell proliferation-associated increase in the abundance of LIPZ was a result of an increased zinc uptake and to assess the involvement of zinc transporters and metallothionein in this cell proliferation-associated increase in the abundance of LIPZ in 3T3 fibroblasts. Zinc transporters assessed included both zinc importer (Zip1) and zinc exporters (ZnT1, ZnT2 and ZnT4). Growth factors increased the abundance of LIPZ while total cellular zinc concentration remained unaffected, demonstrating that LIPZ was responsive to the increased needs for zinc during growth factor-stimulated cell proliferation. Growth factors also increased net zinc retention as indicated by higher 65zinc radioactivity and elevated mRNA levels of Zip1, ZnT1 and ZnT4. Although zinc is essential to cell proliferation, excessive cellular zinc accumulation causes cytotoxicity. Collectively, these observations suggest that increase in the abundance of LIPZ during growth factor-stimulated cell proliferation was due to increased net retention of extracellular zinc, which was apparently achieved through a coordinated up-regulation of the expression of transporters involved in both zinc influx and efflux to ensure adequate supply of zinc to sustain cell proliferation, yet to prevent potential zinc cytotoxicity in 3T3 cells.
Simpson
Madeline
M
Food, Nutrition and Health Program, The University of British Columbia, Vancouver, BC, Canada V6T 1Z4.
Xu
Zhaoming
Z
D016475:3T3 Cells; D000818:Animals; D027682:Cation Transport Proteins / Q000235:genetics; D002455:Cell Division / Q000187:drug effects; D004815:Epidermal Growth Factor / Q000494:pharmacology; D015870:Gene Expression; D006706:Homeostasis; D007334:Insulin-Like Growth Factor I / Q000494:pharmacology; D042541:Intracellular Space / Q000737:chemistry; D008668:Metallothionein / Q000032:analysis; D051379:Mice; D010982:Platelet-Derived Growth Factor / Q000494:pharmacology; D012333:RNA, Messenger / Q000032:analysis; D015032:Zinc / Q000032:analysis* / Q000378:metabolism*
D027682:Cation Transport Proteins; D010982:Platelet-Derived Growth Factor; D012333:RNA, Messenger; C485803:Slc30a1 protein, mouse; C109053:Slc30a4 protein, mouse; C485744:Slc39a1 protein, mouse; D004815:Epidermal Growth Factor; D007334:Insulin-Like Growth Factor I; D008668:Metallothionein; D015032:Zinc